JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2006;59:759-763; doi:10.1136/jcp.2005.034108
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hassan, I A
Right arrow Articles by Denning, D W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hassan, I A
Right arrow Articles by Denning, D W
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Fungal Infections

ORIGINAL ARTICLE

Audit of laboratory mycology services for the management of patients with fungal infections in the northwest of England

I A Hassan1, P Critten2, B Isalska1, D W Denning3

1 Department of Microbiology CSB, SMUHT Wythenshawe Hospital, Manchester, UK
2 Microbiology Laboratory HPA CSB, Wythenshawe Hospital
3 Education and Research Centre, Wythenshawe Hospital

Correspondence to:
I A Hassan
Department of Microbiology CSB, SMUHT Wythenshawe Hospital, Manchester M23 9LT, UK; ibrahim.hassan{at}smuht.nwest.nhs.uk or ihassan{at}doctors.org.uk Background: Fungal infection is increasingly recognised as an important cause of morbidity and mortality, especially in immunocompromised patients. Little information exists on laboratory services available and the methods used by general microbiology laboratories to diagnose these important infections.

Aim: To investigate the services microbiology laboratories in northwest England provide towards the diagnosis and management of superficial and deep fungal infections.

Methods: A questionnaire was sent to laboratories to get a holistic view of the support given to clinicians looking after patients with fungal infections. The aim was not to investigate details of each laboratory’s standard operating procedures.The completed questionnaires, which formed the basis of this report, were returned by all 21 laboratories which were recruited. This study was conducted between March 2004 and September 2004.

Results: Services were provided to District General Hospitals and to six tertiary centres, including eight teaching hospitals by 16 laboratories. Their bed capacity was 250–1300 beds. Total specimens (including bacterial and viral) processed annually were 42 000–500 000 whereas fungal ones were 560–5400.

Conclusion: In most microbiology laboratories of northwest England, clinicians were aware of the potential of fungal pathogens to cause infections especially in immunocompromised patients. Additional measures such as prolonged incubation of samples were introduced to improve fungal yield from patients at high risk. It is necessary to train and educate laboratory and medical staff about the role of serology and molecular methods in diagnosis and management of patients with fungal infection.


Abbreviations: NEQAS, National External Quality Assessment Scheme







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.